Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex32.htm |
| EX-31.2 - EXHIBIT 31.2 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex31-1.htm |
| EX-21 - EXHIBIT 21 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex21.htm |
| EX-10.10 - EXHIBIT 10.10 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex10-10.htm |
| EX-10.9 - EXHIBIT 10.9 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex10-9.htm |
| EX-10.4 - EXHIBIT 10.4 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex10-4.htm |
| EX-10.3 - EXHIBIT 10.3 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex10-3.htm |
| EX-10.2 - EXHIBIT 10.2 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex10-2.htm |
| EX-10.1 - EXHIBIT 10.1 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex10-1.htm |
| EX-4.4 - EXHIBIT 4.4 - Petros Pharmaceuticals, Inc. | tm2111173d1_ex4-4.htm |
| 10-K - FORM 10-K - Petros Pharmaceuticals, Inc. | tm2111173d1_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Petros Pharmaceuticals, Inc. and Subsidiaries on Form S-3 (No. 333-252573) and Form S-8 (No. 333-252339) of our report dated March 31, 2021, on our audits of the consolidated financial statements as of December 31, 2020 and 2019 and for each of the years then ended, which report is included in this Annual Report on Form 10-K to be filed on or about March 31, 2021.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
March 31, 2021